Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs

被引:9
作者
Abraham, Amanda J. [1 ,2 ]
O'Brien, Lauren A. [1 ]
Knudsen, Hannah K. [3 ,4 ]
Bride, Brian E. [5 ]
Smith, G. Rush [1 ]
Roman, Paul M. [1 ,2 ]
机构
[1] Univ Georgia, Owens Inst Behav Res, Athens, GA 30602 USA
[2] Univ Georgia, Dept Sociol, Athens, GA 30602 USA
[3] Univ Kentucky, Dept Behav Sci, Lexington, KY 40506 USA
[4] Univ Kentucky, Ctr Drug & Alcohol Res, Lexington, KY 40506 USA
[5] Univ Georgia, Sch Social Work, Athens, GA 30602 USA
关键词
HIV testing; Substance use disorders; Treatment programs; DRUG-ABUSE-TREATMENT; SEXUALLY-TRANSMITTED INFECTIONS; C VIRUS-INFECTION; HEPATITIS-C; ON-SITE; INNOVATION ADOPTION; HEALTH-SERVICES; PREVENTION; HIV/AIDS; RISK;
D O I
10.1016/j.jsat.2012.03.004
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Racial and ethnic minorities and injection drug users (IDUs) are at increased risk of HIV infection. However, the associations between these caseload characteristics and the availability of onsite HIV testing in substance use disorder treatment programs are unknown. This study uses data collected in 2008-2009 from 198 program administrators of treatment programs participating in the National Institute on Drug Abuse's Clinical Trials Network to address. this gap in the literature. Results show positive associations between the percentages of African American, Hispanic, and IDU patients and the odds of offering non-rapid onsite HIV testing versus no onsite testing. The associations between racial/ethnic composition and the availability of rapid HIV testing were more complicated. These findings suggest that many programs are responding to the needs of at-risk populations. However, programs and their patients may benefit from greater adoption of rapid testing which is less costly and better ensures that patients receive their results. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 62 条
[41]  
McCree DH, 2010, AFRICAN AMERICANS AND HIV/AIDS: UNDERSTANDING AND ADDRESSING THE EPIDEMIC, P1
[42]  
Mee-Lee D., 1996, ASAM PATIENT PLACEME
[43]  
METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049
[44]  
Molitor F, 1998, WESTERN J MED, V168, P93
[45]  
National Alliance of State & Territorial AIDS Directors, 2009, REP CTR DIS CONTR PR
[46]  
National Medical Association, 2010, NMA HIV AIDS PROGR
[47]   CHANGES IN SEXUALLY-TRANSMITTED DISEASE RATES AFTER HIV TESTING AND POSTTEST COUNSELING, MIAMI, 1988 TO 1989 [J].
OTTEN, MW ;
ZAIDI, AA ;
WROTEN, JE ;
WITTE, JJ ;
PETERMAN, TA .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1993, 83 (04) :529-533
[48]   Outpatient substance abuse treatment and HIV prevention: An update [J].
Pollack, HA ;
D'Aunno, T ;
Lamar, B .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2006, 30 (01) :39-47
[49]   HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005 [J].
Pollack, Harold A. ;
D'Aunno, Thomas .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2010, 38 (04) :307-316
[50]   Decline in HIV infectivity following the introduction of highly active antiretroviral therapy [J].
Porco, TC ;
Martin, JN ;
Page-Shafer, KA ;
Cheng, A ;
Charlebois, E ;
Grant, RM ;
Osmond, DH .
AIDS, 2004, 18 (01) :81-88